Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome.
Transfusion related acute lung injury (TRALI) is one of the complications of blood transfusion and can result in major morbidity or mortality. The diagnosis depends upon the application of strict clinical criteria defining acute lung injury (ALI) and a temporal relationship to blood transfusion. We present the clinical and immunogenetic findings of 96 suspected TRALI cases investigated between 1996 and 2004. During this time period the national haemovigilance scheme (UK) defined TRALI as a reaction occurring either during or within 24 h of blood transfusion. Using clinical, laboratory and post mortem evidence, 64/96 cases could be defined as TRALI in our series. Sensitive techniques were employed to screen for HLA class I, class II and granulocyte specific antibodies in donor serum. Donor derived antibodies were detected in 58/64 (90%) of cases. Recipient derived DNA or cells were not always available but incompatibility was confirmed by the presence of the cognate antigen on recipient leucocytes or by crossmatching in 47/64 (73%) of cases. Cases referred prior to 2001 were not tested for HLA class II antibodies. By applying strict clinical criteria and using sensitive techniques a white blood cell antibody mediated immunological pathophysiology can be implicated in the majority TRALI cases.
Win
Nay
N
Red Cell Immunohaematology, National Health Service Blood and Transplant (NHSBT), Tooting Centre, London, UK. nay.win@nhsbt.nhs.uk
Massey
Edwin
E
Lucas
Geoff
G
Sage
Deborah
D
Brown
Colin
C
Green
Ann
A
Contreras
Marcela
M
Navarrete
Cristina
C
D006098:Granulocytes / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D012128:Respiratory Distress Syndrome / Q000175:diagnosis* / Q000209:etiology* / Q000276:immunology; D065227:Transfusion Reaction; D016896:Treatment Outcome
D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007518:Isoantibodies